Diagnostic and Interventional Cardiology (DAIC) maintains more than 50 comparison charts of product specifications from ...
EP Lab
This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.
![product comparison charts for cardiology and health IT systems](/sites/default/files/styles/content_feed_large/public/field/image/DAIC%20comparison%20chart%20image.jpg?itok=Atc6ge36)
June 9, 2022 — Holes help make sponges and English muffins useful (and, in the case of the latter, delicious). Without ...
June 7, 2022 — Stereotaxis, a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
May 24, 2022 — Attune Medical, a pioneering medical device company with a technology platform based on temperature ...
May 18, 2022 — Continuous monitoring with an insertable cardiac monitor (ICM) is shown to be more successful in ...
May 17, 2022 — Results of a new study reveal Black patients hospitalized with atrial fibrillation (AF) are under ...
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
May 17, 2022 — Results from a new study show success of intended same day discharge (SDD) improves over time for ...
May 17, 2022 — Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding ...
May 17, 2022 — On the heels of its landmark valvular heart disease (VHD) prevalence abstract published in Journal of the ...
Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in ...
May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...
![The global cardiogenic shock market was valued at US$ 3.29 Bn in 2021, and is expected to reach US$ 6.32 Bn by 2032, expanding at a CAGR of 6.2% over the 2022-2032 time frame.](/sites/default/files/styles/content_feed_large/public/field/image/Screen%20Shot%202022-05-12%20at%209.46.21%20AM.png?itok=sqhwQwCa)
The global cardiogenic shock market was valued at US$ 3.29 Bn in 2021, and is expected to reach US$ 6.32 Bn by 2032 ...
![Primary tabs View(active tab) Edit Delete Revisions Entityqueue Devel Open configuration options Open configuration options Videos | Venous Therapies | June 27, 2017 VIDEO: How the Ekos Thrombolytic Technology Works to Dissolve Clots Open Related Chest Pain Imaging Content: configuration options Venous Thrombolytic System Demonstration Play Mute Remaining Time -3:23 Picture-in-Picture Fullscreen This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat dee](/sites/default/files/styles/content_feed_large/public/field/image/Screen%20Shot%202022-05-09%20at%2010.38.10%20AM.png?itok=EmhuqQwx)
Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of ...
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
![The trends of an increased interest in RPM and potential cost savings have inspired companies to participate in this slowly evolving paradigm shift and improve technology](/sites/default/files/styles/content_feed_large/public/field/image/Screen%20Shot%202022-05-05%20at%2011.33.31%20AM.png?itok=ORi0qWBG)
I work at Emory University in a multidisciplinary group that is employing medical technologies to improve our ...
![With the increase of patients experiencing heart failure and clinical challenges to manage advanced heart failure conditions, therapies with implantable devices have become an essential treatment method](/sites/default/files/styles/content_feed_large/public/field/image/GettyImages-856207652.jpg?itok=rxA8ax_O)
The current standard of care for heart failure (HF) is guideline-directed medical therapy combined with device-based ...
May 4, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...